The impact of the COVID-19 pandemic had an unprecedented effect on the theatrical exhibition industry. We temporarily closed our theatres in the U.S. and Latin America during March of 2020 at the onset of the COVID-19 outbreak. We reopened theatres as soon as local restrictions and the status of the COVID-19 pandemic would allow. All of our domestic and international theatres were reopened by the end of 2021. After reopening our theatres, we faced ongoing challenges with the significant reduction in the volume of new film releases. The industry has made significant progress in its recovery from the COVID-19 pandemic; however its ongoing recovery continues to be contingent upon several key factors, including the volume of new film content available, which has also been impacted by the recent writers’ and actors’ guild strikes, the box office performance of new film content released, the duration of the exclusive theatrical release window, and evolving consumer behavior with competition from other forms of in-and-out-of-home entertainment.

During the years ended December 31, 2021 and 2022, the Company received an aggregate of approximately $2.8 in government assistance pursuant to (i) payroll continuation support programs under the CARES Act, (ii) various grants provided in certain states intended to cover janitorial and personal protection equipment costs incurred by the Company in response to local regulations and (iii) subsidies for certain payroll costs in certain international locations. The Company has met all applicable conditions related to the government assistance received. The government assistance received was reflected as credits to salaries and wages, utilities and other costs, and general and administrative expenses in the consolidated statements of loss.

In 2020, Company management approved and announced a restructuring plan to realign its operations to create a more efficient cost structure (referred to herein as the “Restructuring Plan”) in response to the COVID-19 pandemic. The Restructuring Plan primarily included a headcount reduction at its domestic corporate office and the permanent closure of certain domestic and international theatres.

The following table summarizes activity recorded during the years ended December 31, 2021 and 2022:


	U.S. Operating Segment									International Operating Segment								Consolidated
	Employee-related Costs			Facility Closure Costs			Total Charges			Employee-related Costs		Facility Closure Costs			Total Charges			Employee-related Costs			Facility Closure Costs			Total Charges
Reserve balance at January 1, 2021	$	0.9		$	5.7		$	6.6		$	—	$	0.1		$	0.1		$	0.9		$	5.8		$	6.7
Amounts paid		(0.4	)		(3.9	)		(4.3	)		—		—			—			(0.4	)		(3.9	)		(4.3	)
Reserve adjustments (1)		(0.1	)		(0.9	)		(1.0	)		—		—			—			(0.1	)		(0.9	)		(1.0	)
Reserve balance at December 31, 2021	$	0.4		$	0.9		$	1.3		$	—	$	0.1		$	0.1		$	0.4		$	1.0		$	1.4
Amounts paid		(0.4	)		(0.5	)		(0.9	)		—		—			—			(0.4	)		(0.5	)		(0.9	)
Reserve adjustments (1)		—			(0.4	)		(0.4	)		—		(0.1	)		(0.1	)		—			(0.5	)		(0.5	)
Reserve balance at December 31, 2022	$	—		$	—		$	—		$	—	$	—		$	—		$	—		$	—		$	—